PortfoliosLab logoPortfoliosLab logo
EONGY vs. AZN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EONGY vs. AZN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in E.ON SE ADR (EONGY) and AstraZeneca PLC (AZN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EONGY achieves a 16.21% return, which is significantly higher than AZN's -0.75% return. Over the past 10 years, EONGY has underperformed AZN with an annualized return of 14.65%, while AZN has yielded a comparatively higher 15.97% annualized return.


EONGY

1D
-0.09%
1M
-3.35%
YTD
16.21%
6M
23.24%
1Y
22.28%
3Y*
25.00%
5Y*
16.33%
10Y*
14.65%

AZN

1D
-1.94%
1M
-4.78%
YTD
-0.75%
6M
1.57%
1Y
22.51%
3Y*
8.94%
5Y*
11.28%
10Y*
15.97%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EONGY vs. AZN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EONGY
E.ON SE ADR
16.21%68.77%-9.82%41.96%-25.33%30.17%7.27%11.88%-7.04%62.83%
AZN
AstraZeneca PLC
-0.75%43.30%-0.62%1.44%19.14%19.66%3.12%35.68%13.86%33.10%

Correlation

The correlation between EONGY and AZN is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.27

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.27

Correlation (10Y)
Calculated over the trailing 10-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Sep 10, 2007

0.33

Fundamentals

Market Cap

EONGY:

$55.84B

AZN:

$279.03B

EPS

EONGY:

€1.33

AZN:

$6.66

PE Ratio

EONGY:

13.93

AZN:

26.85

PEG Ratio

EONGY:

0.08

AZN:

0.04

PS Ratio

EONGY:

0.64

AZN:

4.62

PB Ratio

EONGY:

2.20

AZN:

5.90

Total Revenue (TTM)

EONGY:

€75.47B

AZN:

$60.44B

Gross Profit (TTM)

EONGY:

€15.73B

AZN:

$49.37B

EBITDA (TTM)

EONGY:

€9.86B

AZN:

$20.47B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EONGY vs. AZN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EONGY
EONGY Risk / Return Rank: 7171
Overall Rank
EONGY Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
EONGY Sortino Ratio Rank: 6565
Sortino Ratio Rank
EONGY Omega Ratio Rank: 6464
Omega Ratio Rank
EONGY Calmar Ratio Rank: 7676
Calmar Ratio Rank
EONGY Martin Ratio Rank: 7575
Martin Ratio Rank

AZN
AZN Risk / Return Rank: 6969
Overall Rank
AZN Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 6868
Sortino Ratio Rank
AZN Omega Ratio Rank: 6464
Omega Ratio Rank
AZN Calmar Ratio Rank: 7171
Calmar Ratio Rank
AZN Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EONGY vs. AZN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for E.ON SE ADR (EONGY) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EONGYAZNDifference
Sharpe ratioReturn per unit of total volatility

+0.09

Sortino ratioReturn per unit of downside risk

-0.10

Omega ratioGain probability vs. loss probability

1.18

1.17

+0.01

Calmar ratioReturn relative to maximum drawdown

2.05

1.47

+0.58

Martin ratioReturn relative to average drawdown

4.71

3.82

+0.89

EONGY vs. AZN - Sharpe Ratio Comparison

The current EONGY Sharpe Ratio is 0.97, which is comparable to the AZN Sharpe Ratio of 0.88. The chart below compares the historical Sharpe Ratios of EONGY and AZN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EONGY vs. AZN - Drawdown Comparison

The maximum EONGY drawdown since its inception was -85.09%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for EONGY and AZN.


Loading charts...

Drawdown Indicators


EONGYAZNDifference

Max Drawdown

Largest peak-to-trough decline

-85.09%

-48.94%

-36.15%

Max Drawdown (1Y)

Largest decline over 1 year

-10.93%

-15.43%

+4.50%

Max Drawdown (3Y)

Largest decline over 3 years

-29.37%

-27.87%

-1.50%

Max Drawdown (5Y)

Largest decline over 5 years

-46.78%

-27.87%

-18.91%

Max Drawdown (10Y)

Largest decline over 10 years

-46.78%

-27.87%

-18.91%

Current Drawdown

Current decline from peak

-25.11%

-14.25%

-10.86%

Average Drawdown

Average peak-to-trough decline

-61.01%

-11.37%

-49.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.74%

5.99%

-1.25%

Volatility

EONGY vs. AZN - Volatility Comparison

The current volatility for E.ON SE ADR (EONGY) is 7.13%, while AstraZeneca PLC (AZN) has a volatility of 7.95%. This indicates that EONGY experiences smaller price fluctuations and is considered to be less risky than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EONGYAZNDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.13%

7.95%

-0.82%

Volatility (6M)

Calculated over the trailing 6-month period

18.19%

17.74%

+0.45%

Volatility (1Y)

Calculated over the trailing 1-year period

23.12%

25.76%

-2.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.58%

24.03%

+0.55%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.16%

24.93%

+0.23%

Dividends

EONGY vs. AZN - Dividend Comparison

EONGY's dividend yield for the trailing twelve months is around 3.12%, more than AZN's 2.98% yield.


PositionTTM20252024202320222021202020192018201720162015
AZN
AstraZeneca PLC
2.98%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
EONGY
E.ON SE ADR
3.12%3.27%4.98%4.06%5.22%2.91%3.33%3.39%2.77%4.35%29.92%5.47%

Financials

EONGY vs. AZN - Financials Comparison

This section allows you to compare key financial metrics between E.ON SE ADR and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B35.00B20222023202420252026
22.18B
15.29B
(EONGY) Total Revenue
(AZN) Total Revenue
Please note, different currencies. EONGY values in EUR, AZN values in USD

EONGY vs. AZN - Profitability Comparison

The chart below illustrates the profitability comparison between E.ON SE ADR and AstraZeneca PLC over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-40.0%-20.0%0.0%20.0%40.0%60.0%80.0%20222023202420252026
12.5%
82.5%
Portfolio components
EONGY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, E.ON SE ADR reported a gross profit of 2.78B and revenue of 22.18B. Therefore, the gross margin over that period was 12.5%.

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.

EONGY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, E.ON SE ADR reported an operating income of 2.62B and revenue of 22.18B, resulting in an operating margin of 11.8%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.

EONGY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, E.ON SE ADR reported a net income of 2.27B and revenue of 22.18B, resulting in a net margin of 10.2%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.


Frequently Asked Questions


EONGY and AZN have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AZN has higher volatility (7.95%) compared to EONGY (7.13%). In terms of maximum drawdown, EONGY dropped -85.09% vs AZN's -48.94%.

EONGY currently has the higher Sharpe Ratio (0.97 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EONGY and AZN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer